Herold Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.34M | Sell |
34,164
-1,802
| -5% | -$334K | 1.33% | 15 |
|
|
2025
Q1 | $7.54M | Sell |
35,966
-1,776
| -5% | -$372K | 1.65% | 9 |
|
|
2024
Q4 | $6.71M | Sell |
37,742
-1,002
| -3% | -$178K | 1.46% | 11 |
|
|
2024
Q3 | $7.65M | Sell |
38,744
-405
| -1% | -$80K | 1.66% | 7 |
|
|
2024
Q2 | $6.72M | Buy |
39,149
+804
| +2% | +$138K | 1.55% | 8 |
|
|
2024
Q1 | $6.98M | Sell |
38,345
-433
| -1% | -$78.9K | 1.69% | 8 |
|
|
2023
Q4 | $6.01M | Buy |
38,778
+682
| +2% | +$106K | 1.66% | 9 |
|
|
2023
Q3 | $5.68M | Buy |
38,096
+2,568
| +7% | +$383K | 1.73% | 9 |
|
|
2023
Q2 | $4.79M | Buy |
35,528
+1,558
| +5% | +$210K | 1.47% | 10 |
|
|
2023
Q1 | $5.41M | Buy |
33,970
+38
| +0.1% | +$6.06K | 1.87% | 8 |
|
|
2022
Q4 | $5.48M | Buy |
33,932
+1,534
| +5% | +$248K | 2.32% | 5 |
|
|
2022
Q3 | $4.35M | Buy |
32,398
+289
| +0.9% | +$38.8K | 2.09% | 5 |
|
|
2022
Q2 | $4.92M | Buy |
32,109
+264
| +0.8% | +$40.4K | 2.19% | 5 |
|
|
2022
Q1 | $5.16M | Buy |
31,845
+1,173
| +4% | +$190K | 1.84% | 6 |
|
|
2021
Q4 | $4.15M | Sell |
30,672
-141
| -0.5% | -$19.1K | 1.61% | 9 |
|
|
2021
Q3 | $3.32M | Buy |
+30,813
| New | +$3.32M | 1.29% | 8 |
|